Formulation optimization and characterization of a novel combination adjuvant for pandemic preparedness
Formulation optimization and characterization of a novel combination adjuvant for pandemic preparedness
用于大流行防范的新型组合佐剂的配方优化和表征
批准号：
463759
负责人：
Falzarano Darryl
金额：
$14.12万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-07-01 至 2023-07-01
中文摘要
翻译
疫苗的新型佐剂是非常需要的，特别是如果它们可以合成而不是来自天然产物。此外，佐剂应该能够诱导更大和更期望的免疫应答-例如定向免疫应答。
英文摘要
Novel adjuvants for vaccines are highly desirable, especially if they can be synthesized instead of being derived from natural products. Additionally, the adjuvant should be capable of inducing a greater and more desired immune response - such as directin
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Supplement - Vaccine efficacy in nonhuman primates against SARS-CoV-2: protection, cross-protection and immune enhancement
-
批准号：443206
-
项目类别：Operating Grants
-
资助金额：$3.64万
-
财政年份：2021
-
负责人：Falzarano Darryl
-
依托单位：
Vaccine efficacy in nonhuman primates against SARS-CoV-2: protection, cross-protection and immune enhancement
-
批准号：430657
-
项目类别：Operating Grants
-
资助金额：$106.31万
-
财政年份：2020
-
负责人：Falzarano Darryl
-
依托单位：
Animal models for SARS-CoV-2: vaccines and immune enhancement
-
批准号：422763
-
项目类别：Operating Grants
-
资助金额：$72.83万
-
财政年份：2020
-
负责人：Falzarano Darryl
-
依托单位：
Sex as a Biological Variable Supplement - Animal models for SARS-CoV-2: vaccines and immune enhancement
-
批准号：424689
-
项目类别：Operating Grants
-
资助金额：$3.64万
-
财政年份：2020
-
负责人：Falzarano Darryl
-
依托单位：
A ONE Health approach for the prevention of MERS-CoV
-
批准号：368988
-
项目类别：Operating Grants
-
资助金额：$49.49万
-
财政年份：2017
-
负责人：Falzarano Darryl
-
依托单位：